Company: CERO
Filing Date: 2025-11-19
Form Type: 10-Q
Source: 0001213900-25-112619
Chunk: 516

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-11-19
Form: 10-Q
Item: Part II, Item 1
Chunk 516
---
0001870404
    
      us-gaap:PrivatePlacementMember

    2025-04-21

    0001870404
    
      cero:FourthPIPEFinancingMember
      us-gaap:SeriesDPreferredStockMember

    2025-04-22

    0001870404
    
      us-gaap:SeriesDPreferredStockMember
      us-gaap:PreferredStockMember

    2025-04-22

    0001870404
    
      us-gaap:SeriesDPreferredStockMember
      us-gaap:PreferredStockMember

    2025-04-22
    2025-04-22

    0001870404
    
      srt:MaximumMember
      us-gaap:SeriesDPreferredStockMember

    2025-04-22
    2025-04-22

    0001870404
    
      us-gaap:SeriesDPreferredStockMember

    2025-04-22
    2025-04-22

    0001870404
    
      us-gaap:SeriesDPreferredStockMember

    2025-06-05
    2025-06-05

    0001870404
    
      us-gaap:SeriesDPreferredStockMember

    2025-06-25
    2025-06-25

    0001870404
    
      us-gaap:SeriesDPreferredStockMember

    2025-07-18
    2025-07-18

    0001870404
    
      srt:MaximumMember
      us-gaap:SeriesDPreferredStockMember

    2025-09-15

    0001870404
    
      srt:MinimumMember
      us-gaap:SeriesDPreferredStockMember

    2025-09-15

    0001870404
    
      us-gaap:SeriesCPreferredStockMember
      us-gaap:CommonStockMember

    2025-01-01
    2025-09-30

    0001870404
    
      us-gaap:SeriesDPreferredStockMember

    2025-07-01
    2025-09-30

    0001870404
    
      cero:KeystonePurchaseAgreementMember